Ardelyx, Inc. ( ARDX) - Key Metrics
ARDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.51 | $0 | $0.09 | $0.08 |
| 2025Q3 | $0.46 | $0 | $0 | $0 |
| 2025Q2 | $0.41 | -$0.08 | -$0.11 | -$0.11 |
| 2025Q1 | $0.31 | -$0.17 | -$0.16 | -$0.16 |
ARDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -872.40 |
| 2025Q3 | ? | -343.89 |
| 2025Q2 | ? | -12.32 |
| 2025Q1 | ? | -7.12 |
ARDX
Price: $5.68
52 week price:
Earnings Per Share: -0.24 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8.1 million
Ebitda: -20.5 millionMarket Capitalization: 1.4 billion